MicroPort Scientific (00853.HK): Proposed Disposal of Controlling Stake in MicroPort Orthopedics (Shanghai) to Tinavi Medical

NewTimeSpace News: On 15 July 2026, MicroPort Scientific (00853.HK) issued an announcement that Suzhou MicroPort Orthopedics (Group) Co., Limited, a subsidiary of the Company, has signed a letter of intent with Beijing Tinavi Medical Technology Co., Ltd. Tinavi plans to purchase the controlling equity interest in MicroPort Orthopedics (Shanghai) Co., Ltd. (the Target Company) from Suzhou MicroPort and other shareholders of the Target, and the consideration will be paid through new share issuance. At present, Suzhou MicroPort holds an 82.29% equity stake in the Target Company.

MicroPort Scientific stated that the Target Company serves as the core operating entity for the Group’s international orthopedic businesses outside China, mainly engaged in hip and knee orthopedic reconstruction products, with business coverage across overseas markets including the United States, Japan and Europe.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.